January 17th, 2022 | 15:57 CET
Which stocks should investors buy? BioNTech, Desert Gold, Unilever in focus
Table of contents:
Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.
Bet on a reverse movement?
Unilever is one of the heavyweights on the stock exchange and, with 4,900 executed orders, is at the top of the most traded shares on Tradegate. The share is currently trading at EUR 44.055, down 6.56%. Those who bet on falling prices at the beginning of that trade were able to achieve a good performance, as the share starts the day at EUR 47.20. The share of BioNTech is also lighter today and was last quoted EUR 169.30 about 1.5% in the red. With over 4,000 executions, the stock ranks second most active company on Tradegate today.
More than one million ounces of gold creates stability
Canadian gold company Desert Gold Ventures surprised the market today with a positive announcement. The company has identified deposits of approximately 1.07 million ounces of gold on its lands in previous exploration and drilling programs - split into Measured and Indicated Mineral Resources of 310,300 ounces and Inferred Mineral Resources of 769,200 ounces of Gold.
Desert Gold’s President & CEO Jared Scharf commented, “The publication of this initial Mineral Resource is a significant milestone for the Company and represents a great starting point. We believe, that with more drilling, the Company will be able to significantly expand on these resources and develop new resource areas like the Gourbassi North West discovery. We expect a busy 2022 as we work towards a 20,000 metre plus drill program with high expectations of the results.”
Desert Gold's shares are up 3.96% to EUR 0.1025. The market capitalization is currently EUR 15 million, hard to imagine that the valuation will remain so low permanently.
Conflict of interest
Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price developments. In this respect, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a "Transaction"). Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.
In this respect, there is a concrete conflict of interest in the reporting on the companies.
In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
For this reason, there is also a concrete conflict of interest.
The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.
Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.
The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.